Organigram (TSE:OGI) Trading Down 0.4% - Here's Why

Key Points

• Organigram Holdings Inc. (TSE:OGI) saw its stock price decrease by 0.4%, trading down to C$2.27 with a significant decline in trading volume, down 81% from its average daily volume.
• The company has a market capitalization of C$303.92 million and a notably high P/E ratio of 189.17, indicating potentially high valuation concerns.
• Organigram focuses on producing high-quality, indoor-grown cannabis products for both medical and recreational use.

Organigram Holdings Inc. (TSE:OGI - )'s stock price was down 0.4% during mid-day trading on Monday . The company traded as low as C$2.22 and last traded at C$2.27. Approximately 32,706 shares were traded during trading, a decline of 81% from the average daily volume of 171,217 shares. The stock had previously closed at C$2.28.

Organigram Stock Performance

The company has a 50-day simple moving average of C$2.07 and a two-hundred day simple moving average of C$1.79. The company has a debt-to-equity ratio of 3.07, a quick ratio of 2.62 and a current ratio of 3.36. The firm has a market capitalization of C$303.92 million, a P/E ratio of 189.17, a PEG ratio of 0.42 and a beta of 2.08.

Organigram Company Profile

Organigram Inc is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.